Method evidence record
Adaptive Clinical Trial Design
Adaptive clinical trial design is a flexible experimental framework, formalised by Bauer and Köhne in 1994, in which pre-specified rules allow the trial to be modified mid-course — adjusting sample size, treatment arms, or randomisation ratios — based on accumulating interim data while rigorously controlling the Type I error rate.
Source record
Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.
Adaptive Design for Clinical Trials
Taxonomic method record · hypothesis-test / experimental-design
- Bauer, P. & Köhne, K. (1994). Evaluation of Experiments with Adaptive Interim Analyses. Biometrics, 50(4), 1029–1041. · DOI 10.2307/2533441
- FDA (2019). Adaptive Design Clinical Trials for Drugs and Biologics — Guidance for Industry. U.S. Food and Drug Administration. · URL
Curated claims
Claims persisted in the evidence ledger, each with its own assessment.
No curated claims yet
This view does not invent a claim assessment when the ledger has none.
Related methods
Generated from the method graph and shown as machine-suggested relations — no evidence claim is inferred.